Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Stock Up ∞
The stock has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The firm’s 50 day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- Manufacturing Stocks Investing
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- What is the Shanghai Stock Exchange Composite Index?
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Insider Selling Explained: Can it Inform Your Investing Choices?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
